Literature DB >> 6163214

Interferon-resistant cell line lacks fatty acid cyclooxygenase activity.

K A Chandrabose, P Cuatrecasas, R Pottathil, D J Lang.   

Abstract

A clone of L1210 mouse leukemia cells selected for resistance to both the antiviral and anticellular properties of mouse interferon were essentially devoid of fatty acid cyclooxygenase activity. Experiments in which broken cell preparations were mixed or the two cell types were cultivated together failed to indicate the presence of a diffusible enzyme inhibitor. Fatty acid lipoxygenase activity of similar magnitude was detectable in both cell types. A selective impairment of fatty acid cyclooxygenase in interferon-resistant cells is consistent with recently described data suggesting that this enzyme may play a crucial role in mediating the antiviral and anticellular effects of interferon.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163214     DOI: 10.1126/science.6163214

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  4 in total

1.  The role of free radical scavengers, inhibitors of prostaglandin synthesis, and hypomethylating agents in reactivation of latent herpes simplex virus.

Authors:  S Sienko; A M Eis-Hübinger; K E Schneweis
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  Pleiotropic activities of human interferons are mediated by multiple response pathways.

Authors:  R L Forti; W M Mitchell; W C Hubbard; R J Workman; J T Forbes
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

3.  Interferon enhances prostacyclin production by cultured vascular endothelial cells.

Authors:  A Eldor; R Fridman; I Vlodavsky; E Hy-Am; Z Fuks; A Panet
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

4.  Inhibition of interferon-mediated induction of indoleamine 2,3-dioxygenase in mouse lung by inhibitors of prostaglandin biosynthesis.

Authors:  S Sayama; R Yoshida; T Oku; J Imanishi; T Kishida; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.